RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret Balance Sheet Health
Financial Health criteria checks 4/6
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret has a total shareholder equity of TRY909.8M and total debt of TRY55.3M, which brings its debt-to-equity ratio to 6.1%. Its total assets and total liabilities are TRY1.0B and TRY113.1M respectively.
Key information
6.1%
Debt to equity ratio
₺55.26m
Debt
| Interest coverage ratio | n/a |
| Cash | ₺139.83m |
| Equity | ₺909.81m |
| Total liabilities | ₺113.14m |
| Total assets | ₺1.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RTALB's short term assets (TRY252.2M) exceed its short term liabilities (TRY82.7M).
Long Term Liabilities: RTALB's short term assets (TRY252.2M) exceed its long term liabilities (TRY30.5M).
Debt to Equity History and Analysis
Debt Level: RTALB has more cash than its total debt.
Reducing Debt: RTALB's debt to equity ratio has increased from 1.5% to 6.1% over the past 5 years.
Debt Coverage: RTALB's debt is well covered by operating cash flow (96.4%).
Interest Coverage: Insufficient data to determine if RTALB's interest payments on its debt are well covered by EBIT.